Article Per Year (5 Year)
p-Index From 2021 - 2026
1.325
P-Index
This Author published in this journals
All Journal Health Science Journal of Indonesia Sari Pediatri Paediatrica Indonesiana Media Ilmu Kesehatan
Pustika Amalia Wahidiyat
Departemen Ilmu Kesehatan Anak Fakultas Kedokteran Universitas Indonesia/RS. Dr. Cipto Mangunkusumo, Jakarta
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health

Published : 21 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 21 Documents
Search

 1   2   3 
Survival of thalassemia patients at Dr. Cipto Mangunkusumo Hospital: a single center retrospective study Teny Tjitra Sari; Damayanti Angelina; Ludi Dhyani Rahmartani; Anna Mira Lubis; Pustika Amalia Wahidiyat
Paediatrica Indonesiana Vol. 66 No. 3 (2026): May 2026
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background Thalassemia is a serious health challenge around the world, especially in countries within the “Thalassemia belt,” including Indonesia. The effectiveness of treatment for thalassemia is often measured by how well patients survive and thrive. However, the information is still limited on the survival of thalassemia patients in Indonesia. Objective To evaluate factors related to mortality risk,  characteristics and age distribution of thalassemia patients at Dr. Cipto Mangunkusumo National Central General Hospital (CMNH), Indonesia. Methods Using patient medical records from the Thalassemia Center of CMNH, covering the years 2017 to 2023, we examined patient characteristics, age distribution, and survival rates. To understand survival over time, the Kaplan–Meier and Cox regression tests were used. Results The 562 thalassemia patients studied had an average age of 18.3 years and 286 (51%) were male. The majority of patients (55.8%) had β-thalassemia. Most patients were between 11 and 20 years old (38.6%), and nearly half of them (49%) received deferiprone as their iron chelation therapy. Patients with mean serum ferritin ≥ 2,500 ng/mL (87.7%) had lower survival than patients with mean serum ferritin < 2,500 ng/mL (12.3%), but the difference was not statistically significant [hazard ratio (HR) 1.23; 95%CI 0.29 to 5.16; P=0.779]. Conclusion At CMNH, most thalassemia patients were adolescents or young adults, and β-thalassemia was the most common subtype. Patients with mean serum ferritin ≥2,500 ng/mL had a higher estimated mortality risk than those with lower levels (HR 1.23; 95% CI 0.29–5.16), although the association was not statistically significant.
Co-Authors A Harahap Agus Kosasih Anna Mira Lubis Arum Margi Kusumawardani Batubara, Jose Bernie Endyarni Medise Bidasari Lubis Damayanti Angelina Damayanti Rusli Sjarif Damayanti Sekarsari Dewi Sharon Simorangkir Dian Puspita Sari Dina Muktiarti, Dina Djajadiman Gatot Elida Marpaung Felix Liauw Fitri Primacakti, Fitri Gatot Djajadiman H.F. Wulandari Hanifah Oswari Harapan Parlindungan Ringoringo Henny A. Puspitasari Hikari Ambara Sjakti, Hikari Ambara I Setianingsih Iswari Setianingsih Iswari Setianingsih Ita M. Nainggolan Joedo Prihartono Ken Ritchie, Ni Ludi Dhyani Rahmartani Mikhael Yosia Mikhael Yosia Murti Andriastuti, Murti N S Marzuki Nadhifa Tazkia Ramadhani Naela Fadhila Nafrialdi Nafrialdi Ni Ken Ritchie Ninik Sukartini Nitish Basant Adnani Nitish Basant Adnani Novie Amelia Chozie Partini Pudjiastuti Trihono Putu Junara Putra R A Taufani Rinawati Rohsiswatmo Rosalina Dewi Roeslani, Rosalina Dewi Sheila Claudhea Salsabila Siti Ayu Putriasih Siti Ayu Putriasih Stephen Diah Iskandar Stephen Diah Iskandar Stephen Diah Iskandar Tenny Tjitrasari Teny Tjitra Sari, Teny Tjitra Tjhin Wiguna Vivian Soetikno Yovita Ananta Zakiudin Munasir